Electroporation of Mycobacterium and overexpression of antigens in Mycobacteria

Details for Australian Patent Application No. 2005312062 (hide)

Owner Aeras Global TB Vaccine Foundation

Inventors Sun, Ronggai; Hone, David Michael; Sadoff, Jerald C

Agent Halfords IP

Pub. Number AU-B-2005312062

PCT Pub. Number WO2006/060332

Priority 60/631,977 01.12.04 US

Filing date 29 November 2005

Wipo publication date 8 June 2006

Acceptance publication date 17 November 2011

International Classifications

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/060332 Priority application(s): WO2006/060332

17 November 2011 Application Accepted

  Published as AU-B-2005312062

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005312065-Cellular signaling pathway based assays, reagents and kits

2005312061-Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof